These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38514330)

  • 21. Familial hypercholesterolemia in China half a century: A review of published literature.
    Peng J; Wu X; Wang S; Zhang S; Wang X; Liu Z; Hong J; Ye P; Lin J
    Atheroscler Suppl; 2019 Mar; 36():12-18. PubMed ID: 30876527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing Premature Coronary Artery Disease in Malaysia by Early Identification of Familial Hypercholesterolemia Using the Familial Hypercholesterolemia Case Ascertainment Tool (FAMCAT): Protocol for a Mixed Methods Evaluation Study.
    Ramli AS; Qureshi N; Abdul-Hamid H; Kamal A; Kanchau JD; Shahuri NS; Akyea RK; Silva L; Condon L; Abdul-Razak S; Al-Khateeb A; Chua YA; Mohamed-Yassin MS; Baharudin N; Badlishah-Sham SF; Abdul Aziz AF; Mohd Kasim NA; Sheikh Abdul Kadir SH; Kai J; Leonardi-Bee J; Nawawi H
    JMIR Res Protoc; 2023 Jun; 12():e47911. PubMed ID: 37137823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Familial hypercholesterolemia among unselected contemporary patients presenting with first myocardial infarction: Prevalence, risk factor burden, and impact on age at presentation.
    Mortensen MB; Kulenovic I; Klausen IC; Falk E
    J Clin Lipidol; 2016; 10(5):1145-1152.e1. PubMed ID: 27678431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.
    Sturm AC; Knowles JW; Gidding SS; Ahmad ZS; Ahmed CD; Ballantyne CM; Baum SJ; Bourbon M; Carrié A; Cuchel M; de Ferranti SD; Defesche JC; Freiberger T; Hershberger RE; Hovingh GK; Karayan L; Kastelein JJP; Kindt I; Lane SR; Leigh SE; Linton MF; Mata P; Neal WA; Nordestgaard BG; Santos RD; Harada-Shiba M; Sijbrands EJ; Stitziel NO; Yamashita S; Wilemon KA; Ledbetter DH; Rader DJ;
    J Am Coll Cardiol; 2018 Aug; 72(6):662-680. PubMed ID: 30071997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study.
    Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL;
    Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia.
    Chan DC; Pang J; Hooper AJ; Bell DA; Bates TR; Burnett JR; Watts GF
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1704-1714. PubMed ID: 29408959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of New Genetic Determinants in Pediatric Patients with Familial Hypercholesterolemia Using a Custom NGS Panel.
    Rutkowska L; Sałacińska K; Salachna D; Matusik P; Pinkier I; Kępczyński Ł; Piotrowicz M; Starostecka E; Lewiński A; Gach A
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Array-based resequencing for mutations causing familial hypercholesterolemia.
    Chiou KR; Charng MJ; Chang HM
    Atherosclerosis; 2011 Jun; 216(2):383-9. PubMed ID: 21376320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of New Copy Number Variation and the Evaluation of a CNV Detection Tool for NGS Panel Data in Polish Familial Hypercholesterolemia Patients.
    Rutkowska L; Pinkier I; Sałacińska K; Kępczyński Ł; Salachna D; Lewek J; Banach M; Matusik P; Starostecka E; Lewiński A; Płoski R; Stawiński P; Gach A
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of LDLR and PCSK9 pathogenic variants in Japanese heterozygous familial hypercholesterolemia patients.
    Hori M; Ohta N; Takahashi A; Masuda H; Isoda R; Yamamoto S; Son C; Ogura M; Hosoda K; Miyamoto Y; Harada-Shiba M
    Atherosclerosis; 2019 Oct; 289():101-108. PubMed ID: 31491741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incorporation of genetic testing significantly increases the number of individuals diagnosed with familial hypercholesterolemia.
    Brown EE; Byrne KH; Davis DM; McClellan R; Leucker T; Jones SR; Martin SS
    J Clin Lipidol; 2020; 14(3):331-338. PubMed ID: 32220565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic analysis of familial hypercholesterolemia in Asian Indians: A single-center study.
    Setia N; Movva S; Balakrishnan P; Biji IK; Sawhney JPS; Puri R; Arora A; Puri RD; Saxena R; Mishra S; Apte S; Kulshrestha S; Ramprasad VL; Verma IC
    J Clin Lipidol; 2020; 14(1):35-45. PubMed ID: 32044282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of mutations in index patients with familial hypercholesterolemia in Singapore: Single center study.
    Pek SLT; Dissanayake S; Fong JCW; Lin MX; Chan EZL; Tang JI; Lee CW; Ong HY; Sum CF; Lim SC; Tavintharan S
    Atherosclerosis; 2018 Feb; 269():106-116. PubMed ID: 29353225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Founder effects facilitate the use of a genotyping-based approach to molecular diagnosis in Swedish patients with familial hypercholesterolaemia.
    Benedek P; Jiao H; Duvefelt K; Skoog T; Linde M; Kiviluoma P; Kere J; Eriksson M; Angelin B
    J Intern Med; 2021 Aug; 290(2):404-415. PubMed ID: 33955087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetic spectrum of familial hypercholesterolemia in the central south region of China.
    Xiang R; Fan LL; Lin MJ; Li JJ; Shi XY; Jin JY; Liu YX; Chen YQ; Xia K; Zhao SP
    Atherosclerosis; 2017 Mar; 258():84-88. PubMed ID: 28235710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of PCSK9 and LDLR genetic variants in Familial Hypercholesterolemia (FH) patients in India.
    Reddy LL; Shah SAV; Ponde CK; Dalal JJ; Jatale RG; Dalal RJ; Rajani RM; Pillai SK; Vanjani CV; Ashavaid TF
    J Hum Genet; 2021 Oct; 66(10):983-993. PubMed ID: 33864011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simplified Canadian Definition for Familial Hypercholesterolemia.
    Ruel I; Brisson D; Aljenedil S; Awan Z; Baass A; Bélanger A; Bergeron J; Bewick D; Brophy JM; Brunham LR; Couture P; Dufour R; Francis GA; Frohlich J; Gagné C; Gaudet D; Grégoire JC; Gupta M; Hegele RA; Mancini GBJ; McCrindle BW; Pang J; Raggi P; Tu JV; Watts GF; Genest J
    Can J Cardiol; 2018 Sep; 34(9):1210-1214. PubMed ID: 30093300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of mutant genes associated with autosomal dominant familial hypercholesterolemia: integration and evolution of genetic diagnosis.
    Di Taranto MD; D'Agostino MN; Fortunato G
    Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):979-87. PubMed ID: 26165249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Resuscitated Case of Acute Myocardial Infarction with both Familial Hypercholesterolemia Phenotype Caused by Possibly Oligogenic Variants of the PCSK9 and ABCG5 Genes and Type I CD36 Deficiency.
    Nishikawa R; Furuhashi M; Hori M; Ogura M; Harada-Shiba M; Okada T; Koseki M; Kujiraoka T; Hattori H; Ito R; Muranaka A; Kokubu N; Miura T
    J Atheroscler Thromb; 2022 Apr; 29(4):551-557. PubMed ID: 33642439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.